Data / Drug companies / Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.: 24 products in the FDA NDC directory, labeler code 12666
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. (labeler code 12666) lists 24 products in the FDA National Drug Code Directory. By type: 24 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 28, 2026.
The request: Watch Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. (FDA labeler code 12666): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 12666
- Products in commercial distribution
- 24
- Packages
- 50
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- July 1, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 23 | 95.8% |
| Bulk ingredients for compounding | 1 | 4.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 24 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lubabegron fumarate | 12666-0029 | Powder | Bulk ingredients | May 28, 2026 |
| Desvenlafaxine succinate | 12666-0023 | Powder | Bulk ingredients for compounding | September 16, 2024 |
| Grapiprant | 12666-0022 | Powder | Bulk ingredients | June 1, 2023 |
| Sitagliptin phosphate anhydrous | 12666-0015 | Powder | Bulk ingredients | August 20, 2012 |
| Olmesartan medoxomil | 12666-0021 | Powder | Bulk ingredients | March 5, 2012 |
| Iron dextran | 12666-0020 | Powder | Bulk ingredients | December 12, 2011 |
| Clopidogrel bisulfate | 12666-0019 | Powder | Bulk ingredients | September 25, 2011 |
| Laropiprant | 12666-0017 | Powder | Bulk ingredients | April 23, 2011 |
| Aliskiren hemifumarate | 12666-0016 | Powder | Bulk ingredients | April 20, 2011 |
| Levetiracetam | 12666-0014 | Powder | Bulk ingredients | November 9, 2010 |
| Sitagliptin phosphate | 12666-0013 | Powder | Bulk ingredients | May 10, 2010 |
| Metaxalone | 12666-0012 | Powder | Bulk ingredients | March 29, 2010 |
| Metoprolol tartrate | 12666-0009 | Powder | Bulk ingredients | December 15, 2009 |
| Telmisartan | 12666-0010 | Powder | Bulk ingredients | December 10, 2009 |
| Quetiapine fumarate | 12666-0008 | Powder | Bulk ingredients | December 10, 2009 |
| Bupropion hydrochloride | 12666-0001 | Powder | Bulk ingredients | June 8, 2009 |
| Methocarbamol | 12666-0003 | Powder | Bulk ingredients | May 20, 2009 |
| Irbesartan | 12666-0011 | Powder | Bulk ingredients | February 15, 2009 |
| Lamotrigine | 12666-0005 | Powder | Bulk ingredients | April 25, 2008 |
| Levalbuterol l-tartrate | 12666-0007 | Powder | Bulk ingredients | April 1, 2008 |
| Bupropion hydrobromide | 12666-0006 | Powder | Bulk ingredients | February 2, 2008 |
| Metoprolol succinate | 12666-0002 | Powder | Bulk ingredients | February 2, 2008 |
| Venlafaxine hydrochloride | 12666-0004 | Powder | Bulk ingredients | November 15, 2006 |
| Metoprolol succinate | 12666-0002 | Powder | Bulk ingredients | July 1, 2006 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.